CARIBOU BIOSCIENCES I
2.7800
07-11月-24 15:59:58
15 分の遅延
株式
+0.0300
+1.09%
本日の幅
2.3700 - 2.9995
ISIN
N/A
ソース
NASDAQ
-
Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
06 11 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
25 9 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
03 9 2024 08:01:11 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
26 8 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
12 8 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
06 8 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
09 7 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
30 5 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
07 5 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
01 5 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
15 4 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
04 4 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
11 3 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
15 2 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
07 1 2024 11:00:00 提供 Nasdaq GlobeNewswire
-
12 12 2023 16:02:00 提供 Nasdaq GlobeNewswire
-
Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
07 11 2023 16:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >